Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 730,367 | 840,440 | 944,073 | 1,049,244 | 1,105,787 |
| Receivables | 18,891 | 24,559 | 17,899 | 63,143 | 68,918 |
| Inventories | N/A | N/A | N/A | 70 | 391 |
| TOTAL | $783,362 | $903,020 | $1,001,749 | $1,141,846 | $1,223,453 |
| Non-Current Assets | |||||
| PPE Net | 210,582 | 195,992 | 188,193 | 201,595 | 294,244 |
| Investments And Advances | 62,490 | 76,021 | 78,565 | 86,090 | 121,064 |
| Intangibles | 90,602 | 125,316 | 131,979 | 158,225 | 163,862 |
| Other Non-Current Assets | 478,219 | 281,412 | 264,856 | 438,636 | 489,376 |
| TOTAL | $841,893 | $678,741 | $663,593 | $884,546 | $1,068,546 |
| Total Assets | $1,625,255 | $1,581,761 | $1,665,342 | $2,026,392 | $2,291,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 140,147 | 26,995 | 9,323 | 10,753 | 13,630 |
| Accrued Expenses | N/A | 108,436 | 110,051 | 114,947 | 110,478 |
| TOTAL | $166,154 | $169,043 | $163,860 | $168,462 | $163,331 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 26,007 | 33,612 | 44,486 | 42,762 | 39,223 |
| Other Non-Current Liabilities | 473,160 | 259,381 | 246,268 | 435,236 | 445,180 |
| TOTAL | $626,029 | $425,448 | $404,330 | $605,247 | $625,083 |
| Total Liabilities | $792,183 | $594,491 | $568,190 | $773,709 | $788,414 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,575 | 55,282 | 53,810 | 52,961 | 49,471 |
| Common Shares | 206 | 202 | 5 | 198 | 196 |
| Retained earnings | -5,673,620 | -5,456,439 | -5,290,528 | -5,078,834 | -4,775,943 |
| Other shareholders' equity | -1,723 | -1,551 | 1,484 | -2,899 | -1,300 |
| TOTAL | $833,072 | $987,270 | $1,097,152 | $1,252,683 | $1,503,585 |
| Total Liabilities And Equity | $1,625,255 | $1,581,761 | $1,665,342 | $2,026,392 | $2,291,999 |